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Abstract
Background: Polyunsaturated n-3 fatty acids (n-3 PUFAs) are reported to protect against high fat diet-induced obesity and
inflammation in adipose tissue. Here we aimed to investigate if the amount of sucrose in the background diet influences the
ability of n-3 PUFAs to protect against diet-induced obesity, adipose tissue inflammation and glucose intolerance.
Methodology/Principal Findings: We fed C57BL/6J mice a protein- (casein) or sucrose-based high fat diet supplemented
with fish oil or corn oil for 9 weeks. Irrespective of the fatty acid source, mice fed diets rich in sucrose became obese
whereas mice fed high protein diets remained lean. Inclusion of sucrose in the diet also counteracted the well-known anti-
inflammatory effect of fish oil in adipose tissue, but did not impair the ability of fish oil to prevent accumulation of fat in the
liver. Calculation of HOMA-IR indicated that mice fed high levels of proteins remained insulin sensitive, whereas insulin
sensitivity was reduced in the obese mice fed sucrose irrespectively of the fat source. We show that a high fat diet decreased
glucose tolerance in the mice independently of both obesity and dietary levels of n-3 PUFAs and sucrose. Of note,
increasing the protein:sucrose ratio in high fat diets decreased energy efficiency irrespective of fat source. This was
accompanied by increased expression of Ppargc1a (peroxisome proliferator-activated receptor, gamma, coactivator 1 alpha)
and increased gluconeogenesis in the fed state.
Conclusions/Significance: The background diet influence the ability of n-3 PUFAs to protect against development of
obesity, glucose intolerance and adipose tissue inflammation. High levels of dietary sucrose counteract the anti-
inflammatory effect of fish oil in adipose tissue and increases obesity development in mice.
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Introduction
Today it is recognized that the potentially harmful effects of
high fat diets relates to not only the amount, but also the type of
dietary fatty acids. Whereas a high intake of saturated and trans
fatty acids has been shown to be associated with increased risk of
cardiovascular diseases in several studies, intake of polyunsaturat-
ed fatty acids (PUFAs) has been associated with lower cardiovas-
cular risk [1,2]. Thus, increasing the relative amount of PUFAs,
both vegetable n-6 PUFAs and marine n-3 PUFA, at the expense
of saturated fat is recommended. It is important to note, however,
that more than 85% of the total dietary PUFA intake in Western
diets today is vegetable n-6 PUFAs, mainly linoleic acid [3]. This is
largely due to the high amount of linoleic acid in corn-, sunflower-,
and soybean-oil used in both home-cooking and in industrially
prepared food [4]. Moreover, animal feeds are enriched with n-6
PUFAs, and although meat production methods are diverse, meat
fatty acid profiles will always reflect that of the animal feed [4].
Thus, the dietary n-3:n-6 PUFA ratio has decreased [3,4]. Al-
though the exchange of saturated fat with vegetable n-6 PUFAs
may have some beneficial effects on human health, a low n-3:n-6
PUFAs ratio is associated with a high risk of several lipid-related
disorders [2,3]. A high intake of n-6 PUFAs has also been asso-
ciated with childhood obesity, [4,5]. Animal studies have shown
that feeding mice a diet containing the n-6 PUFA, linoleic acid,
during the pregnancy-lactation period leads to obesity in the
offspring [6]. This effect, however, is prevented by inclusion of the
n-3 PUFA a-linolenic acid in the diet [6]. These findings are in
line with several studies demonstrating that dietary n-3 PUFAs are
able to limit the development of diet-induced obesity [7–13].
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inflammation [14,15]. Accumulated evidence strongly suggests
that low grade chronic inflammation plays a crucial role in de-
velopment of obesity related insulin resistance [16]. Furthermore,
it should be noted that continuous subcutaneous infusion of lipo-
polysaccharide (LPS) is sufficient to induce adipose tissue inflam-
mation, insulin resistance and obesity in mice [17]. It is also well
documented that n-3 PUFAs are able to limit high fat diet-induced
inflammation in adipose tissue in rodents [18–20]. Both n-3
PUFAs and n-6 PUFAs are substrats for cyclo- and lipoxygenases
and n-3 PUFAs are traditionally assumed to act anti-innflamma-
tory by competitive inhibition of the biosynthesis of arachidonic
acid-derived pro-inflammatory prostaglandins of the 2-series and
furthermore, n-3 PUFA-derived prostaglandins of the 3-series
are believed to be less inflammatory [21,22]. Recent research
furthermore demonstrate that n-3 PUFAs may be converted to
anti-inflammatory cyclooxygenase-2 derived electrophilic oxoder-
ivatives and resolvins [21,22]. Moreover, by activation of the fatty
acid receptor, GPR120, n-3 PUFAs repress LPS- and TNFa-
mediated inflammatory signalling responses, and thereby increase
insulin sensitivity by repressing macrophage-induced adipose tissue
inflammation [23]. Thus, consumption of n-6 PUFAs at the
expense of n-3 PUFAs may aggravate the metabolic consequences
of obesity. Increasing the dietary intake of n-3 PUFAs is therefore
currently recommended by several health authorities.
In order to curb the increasing obesity problem, nutritionists
and authorities have largely focused on reducing fat intake, as
dietary fat contains more energy per gram than proteins and car-
bohydrates. As an alternative to low energy diets, low carbohy-
drate diets are becoming increasingly popular although still con-
troversial. The mechanisms by which such diets induce weigh loss
are still not fully elucidated, but it has been documented that high
protein diets increase energy expenditure in part due to a thermic
effect [24]. We have previously shown that the protein:sucrose
ratio in the background diet determines the adipogenic potential
of dietary n-6 PUFAs in mice [25]. Mice fed n-6 PUFAs in
combination with sucrose became obese, and had a markedly
higher feed efficiency than mice pair-fed n-6 PUFAs in combination
with proteins [25]. In fact, the high-protein fed mice needed
almost 7 times more energy to achieve a weight gain of 1 g than
mice on the high-sucrose diet [25]. The high protein diet led to
an increased glucagon/insulin ratio, concomitant with elevated
cAMP-dependent signaling, induction of COX-mediated prosta-
glandin synthesis and increased expression of uncoupling protein-1
(UCP1) in inguinal subcutaneous white fat [25]. In the present
paper we aimed to investigate whether this phenomenon is
restricted to n-6 PUFAs or if the effects of dietary fats, such as fish
oils, which are considered beneficial to human health, also depend
on the background diets. Furthermore, we aimed to examine
whether the background diet exerts an influence on the ability of
n-3 PUFAs to protect against glucose intolerance and adipose
tissue inflammation.
Results
Sucrose counteracts the obesity-reducing effect of fish
oil in ad libitum fed mice
It is a general notion that intake of fish oil rich in n-3 PUFAs
limits high fat diet-induced obesity in rodents, whereas diets rich in
n-6 PUFAs have been associated with an increased propensity to
develop obesity [6,26]. As we have demonstrated that the
obesogenic effect of n-6 PUFAs is determined by the content of
carbohydrates and protein in the feed [25], we speculated whether
the effect of dietary fats considered health-beneficial, such as fish
oil, might be modulated by different background diets. To answer
this question we fed C57BL/6J male mice isocaloric high fat diets
(Table 1 and 2) containing corn oil or fish oil supplemented with
either protein or sucrose or a conventional low fat diet ad libitum for
9 weeks. Contrasting the general notion that fish oil attenuates
high fat diet-induced obesity, the mice fed the fish oil in com-
bination with sucrose gained as much body weight as the mice fed
corn oil and sucrose (Fig. 1A and B). When combined with
sucrose, fish oil did not reduce the weights of neither epididymal
(eWAT) nor inguinal white adipose tissue (iWAT) mass compared
with corn oil (Fig. 1E and F). Moreover, morphological analyses
demonstrated that the adipocyte size was similar in the two sucrose
fed groups (Fig. 1G). Of note, weight gain in mice fed corn oil or
fish oil plus protein were indistinguishable from that of mice fed
the low fat diet (Fig. 1A). Compared with low fat fed mice, the
weights and adipocytes sizes of eWAT and iWAT in mice fed both
high fat diets in combination with protein tended to be smaller, but
the differences did not reach statistical significance (Fig. 1E, F
and G). Thus, when combined with a high intake of sucrose fish oil
did not prevent obesity. However, high dietary protein content
prevented weight gain and obesity when combined with either
corn or fish oil.
Sucrose, but not protein or fat, strongly stimulates pancreatic
insulin secretion, and accordingly, plasma levels of insulin were
consistently higher in mice fed the sucrose-based diets than in mice
fed the protein-based diets (Fig. 1C). Conversely, the levels of
plasma glucagon were lower and hence, the insulin:glucagon ratio
was about three times higher in mice fed high sucrose than in mice
fed high protein irrespective of whether the diets contained corn
oil or fish oil (Fig. 1D). Collectively, these results indicate that
intake of sucrose and hence increased insulin secretion, abrogates
the protective effects of fish oil in relation to adipocyte hyperplasia
and hypertrophy and thereby the development obesity.
Sucrose counteracts the anti-inflammatory effect of fish
oil in adipose tissue
The ability of n-3 PUFAs to limit high fat diet-induced
inflammation in adipose tissue is well documented [18–20]. As
chronic low grade inflammation in adipose tissue is a characteristic
trait of obesity [14,15] and sucrose abrogates the anti-adipogenic
effect of fish oil, we asked whether the background diet also
attenuated the ability of n-3 PUFAs to protect against adipose
tissue inflammation. Gene expression analyses of eWAT and
iWAT revealed a striking correlation between macrophage- and
inflammatory markers and the intake of sucrose-based diets irres-
pectively of the fat source (Fig. 2A). Expressions of macrophage
marker genes Emr1 (EGF-like module containing, mucin-like,
hormone receptor-like sequence 1 or F4/80) and Cd68, as well as
markers of inflammation Serpine1 (Plasminogen activator inhibitor-
1) and Ccl2 (chemokine (C-C motif) ligand 2), were significantly
higher in adipose tissue from mice fed sucrose than in mice fed
high protein or a low fat diets (Fig. 2A). Moreover, we noticed
a significant increase in the expression of Pparg (peroxisome
proliferator-activated receptor c) in eWAT in the mice fed protein
supplemented with corn oil compared with mice fed protein
supplemented with fish oil (Fig. 2A).
A high fat diet impairs glucose tolerance independent of
macronutrient composition and obesity
As adipose tissue inflammation is causally linked to development
of insulin resistance and glucose intolerance, we subjected mice fed
the different diets for 9 weeks to an intraperitoneal glucose
tolerance test (GTT). Surprisingly, the GTT demonstrated that
Fish Oil, Sucrose and Obesity
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protein-based diets and in the mice fed the sucrose-based diets
(Fig. 2B). Evidently, impaired glucose tolerance was dissociated
from the state of obesity, suggesting that intake of relatively high
amounts of fat reduces glucose tolerance even if weight gain and
expression of inflammatory markers were maintained at low levels.
However, fasting glucose and insulin levels were lower in mice fed
high protein than high sucrose. Thus, calculation of HOMA-IR
indicated that the mice fed proteins remained insulin sensitive,
whereas insulin sensitivity tended to be reduced in the obese mice
fed sucrose even though the difference between sucrose and
protein fed mice did not reach statistical significance (Fig. 2B).
Sucrose does not reduce the ability of fish oil to prevent
diet-induced accumulation of fat in the liver
As the anti-inflammatory effect of n-3 PUFAs in adipose tissue is
well documented, we investigated if the high level of dietary
sucrose reduced uptake of n-3 PUFAs. Thus, GC-MS analyses
were performed to determine the fatty acid composition in red
blood cells, liver and adipose tissues. These analyses demonstrated
the expected enrichment of n-3 PUFA in lipids in red blood cells
and liver (Table 3 and 4). In adipose tissue, the enrichment of n-3
was actually higher in mice fed the sucrose-based fish oil diet than
in the protein-based fish oil diet group (Table 4). However,
inclusion of sucrose in the diet did not reduce the ability of fish oil
to prevent accumulation of fat in the liver (Fig. 3A). When sucrose
was included in the diet, lipid accumulation in livers from fish oil
fed mice was significantly lower than in livers from mice fed corn
oil (Fig. 3A). Moreover, expressions of lipogenic genes seem to be
determined by the sucrose: protein ratio independent of fat source
(Fig. 3B). Thus, the ability of fish oil, but not corn oil, to protect
against diet-induced lipid accumulation in the liver did not seem to
be directly related to the suppression of lipogenic gene expression.
Other hallmarks of n-3 PUFA actions are their ability to
increase fatty acid oxidation and to reduce plasma triacylglycerol
levels [27,28]. Plasma triacylglycerol levels were significantly
reduced in mice fed fish oil in combination with proteins, but
inclusion of sucrose abrogated this effect (Fig. 3C). The higher
plasma levels of b-hydroxybutyrate in mice fed fish oil in
combination with proteins indicated that hepatic fatty acid
oxidation was increased in these mice, and inclusion of sucrose
attenuated this effect (Fig. 3C). Together these results demonstrate
that the protein:sucrose ratio also affects the ability of fish oil to
reduce plasma levels of triacylglycerol and increase fatty acid
oxidation.
Increasing the protein:sucrose ratio in a high fat diet
decreases energy efficiency irrespective of corn or fish oil
supplementation
To verify that the obesity in mice fed fish oil in combination
with sucrose was simply not due to increased energy-intake, feed
intake was recorded and energy efficiency calculated. Obviously,
energy intake was significantly higher in mice fed high fat diets
than that of mice receiving the low fat diet (Fig. 3D). Energy intake
tended to be higher in mice receiving the sucrose diets than in
mice fed the protein-based diets, but this was not statistically
significant (Fig. 3D). Thus, energy efficiency was dramatically
increased in mice receiving sucrose compared to protein, indi-
cating difference in energy expenditure. A simple way to detect
differences in catabolic rate is to subject mice to fasting and
measure the resulting weight loss. Figure 3D shows that mice on
the protein-based diets lost significantly more weight during 18 h
of fasting. This supports the notion that energy expenditure is
higher in mice on a protein-based diet irrespective of whether the
diet is supplemented with corn oil or fish oil.
Expression and activation of UCP1 in brown and white adipose
tissue lead to dissipation of energy in the form of heat, and may
thus protect against diet induced obesity [29]. Gene expression
analyses of adipose tissues demonstrated that expression of Ucp1
(uncoupling protein-1), in mice fed high protein was higher in
iWAT, but not in eWAT or (iBAT) (Fig. 3E). Increased expres-
sion of Ucp1 in iWAT in mice fed the protein-based diets was
accompanied by increased expression of Cpt1b (carnitine palmi-
toyltransferase-1b), Ppargc1a (peroxisome proliferator-activated
receptor gamma coactivator 1 alpha) and Dio2 (deiodinase, iodothy-
ronine, type II), suggesting that iWAT adopted a more brown-like
phenotype (Fig. 3E). Thus, the lean phenotype in mice fed the high
protein diets, appears, at least in part, to result from increased
uncoupled respiration in iWAT.
The obesogenic effect of fish oil is determined by the
macronutrient composition in pair-fed mice
Since energy intake was slightly higher in mice receiving fish oil
in combination with sucrose compared with protein, we decided to
demonstrate directly that this difference was insufficient to account
for the increased adipose tissue mass. Accordingly, mice were pair-
fed the isocaloric diets containing fish oil in combination with
sucrose or protein. To achieve identical energy intake we recorded
Table 1. Macronutrient composition in the diets.
High fish oil High corn oil
Low energy Sucrose Protein Sucrose Protein
Protein (g/kg) 200 200 540 200 540
Casein 200 200 540 200 540
L-Cysteine 3 3 3 3 3
Carbohydrate (g/kg) 619.5 439.5 99.5 439.5 99.5
Corn starch 529.5 9.5 9.5 9.5 9.5
Sucrose 90 430 90 430 90
Fat (g/kg) 70 250 250 250 250
Soybean oil 70 70 70 70 70
Corn oil - - - 180 180
Fish oil - 180 180 - -
doi:10.1371/journal.pone.0021647.t001
Table 2. Fatty acid composition in the diets.
High fish oil High corn oil
Low energy Sucrose Protein Sucrose Protein
SFA (mg/g) 9.6 53.3 50.3 31.4 31.4
MUFA (mg/g) 17.0 54.3 54.0 65.9 65.9
PUFA (mg/g) 36.2 100.6 99.5 120.8 121.2
n-6 (mg/g) 32.7 40.6 38.9 117.3 117.8
n-3 (mg/g) 3.5 60.0 60.6 3.5 3.4
n-3/n-6 0.11 1.48 1.56 0.03 0.03
Abbreviations: SFA, saturated fatty acids; MUFA, monounsaturated fatty acids;
PUFA, polyunsaturated fatty acids.
doi:10.1371/journal.pone.0021647.t002
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and restricted the amount of feed to mice receiving the sucrose-
based feed accordingly. Figure 4A demonstrates that even under
conditions of pair-feeding, the mice receiving high sucrose gained
dramatically more weight than those receiving a high protein diet.
Similarly, as observed in ad libitum fed mice, energy efficiency and
adipose tissue mass were significantly higher when mice were fed
sucrose (Fig. 4B and C). Moreover, energy content in the feces was
similar in both groups and the apparent digestibility was not
increased by increased sucrose amount in the diet (Fig. 4B). Plasma
levels of insulin were higher and glucagon lower in mice fed the
sucrose than protein (Fig. 4D). In iWAT, but not eWAT, we
observed a significant induction of Ppargc1a and Ucp1 expression
indicative of the transformation of iWAT into a more brown-like
depot in protein fed mice (Fig. 4E). In iBAT, expressions of Ucp1
and cyt COXII, (cytochrome c oxidase, subunit II) a marker of
mitochondrial content, were not significantly different in mice fed
protein or sucrose (Fig. 4F).
Lower expression levels of inflammatory markers in eWAT and
iWAT in protein fed mice were also confirmed (Fig. 4E). In
addition, as observed in ad libitum fed mice, glucose tolerance was
similarly affected in protein and sucrose fed mice (Fig. 5A). Fasting
levels of insulin were higher in sucrose+fish oil fed mice than the
two other groups, but an ITT test showed no significant difference
between the groups (Supp Fig. 1). Plasma levels of triacylglycerol
were lower and b-hydroxybutyrate were higher in plasma from
mice fed fish oil in combination with protein than in mice fed fish
oil in combination with sucrose (Fig. 5B). However, expression of
genes involved in fatty acid oxidation was not increased in liver
(Fig. 6B) or in muscle (not shown). Actually, expression of the
classical PPARa target Acox1 (acyl-CoA oxidase 1) was higher in
liver of sucrose fed mice (Fig. 6B). Thus, a possible increase in fatty
acid oxidation in protein fed mice as indicated by the elevated
levels of b-hydroxybutyrate did not appear to be due to increased
expression of genes involved in fatty acid oxidation. Of note,
however, higher expressions of Srebf1 (sterol regulatory element
binding transcription factor 1) as well as Acaca (acetyl-Coenzyme A
carboxylase alpha) and Fasn (fatty acid synthase), indicate that
sucrose overrides the suppressive effect of fish oil on lipogenic gene
expression.
Energy expenditure is reduced in mice fed fish oil in
combination with sucrose
Mice fed fish oil in combination with sucrose exhibited
increased weight gain and an increased feed efficiency indicative
of decreased energy expenditure. Moreover, mice fed fish oil in
combination with sucrose lost significantly less weight during 18 h
of fasting (Fig. 3C). Therefore, we examined whether energy
Figure 1. Sucrose counteracts the obesity-reducing effect of fish oil in ad libitum fed mice. Male C57BL/6 mice (n=8) were fed isocaloric
high fish oil or high corn oil diets with different carbohydrate and protein contents ad libitum for 9 weeks. A: Body weight development of ad libitium
fed mice. (B) Prior to termination the mice were photographed. C–D: Insulin and glucagon levels were measured in plasma in the fed state. E–G: The
weights of epididymal and inguinal white adipose tissues were recorded and sections were stained with hematoxylin and eosin. Data are presented
as means 6 SEM. Different small letters denote significant differences between the groups (P,0.05).
doi:10.1371/journal.pone.0021647.g001
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Accordingly, O2 consumption and CO2 production were mea-
sured by indirect calorimetry. Figure 5C shows that O2 con-
sumption both in the light and the dark periods tended to be lower
in mice fed fish oil in combination with sucrose than with protein.
As expected, mice fed fish oil in combination with sucrose had a
higher CO2 production resulting in a statistically significant higher
RER of about 0.9 indicating a lower rate of fatty acid oxidation
(Fig. 5C).
A diet enriched with fish oil and proteins increases
gluconeogenesis
High circulating levels of insulin combined with a low level of
glucagon translate into reduced cAMP signalling in the liver.
Thus, the observed reduced expressions of Crem (cAMP responsive
element modulator), Pde4c (phosphodiesterase 4C, cAMP specific),
Ppargc1a and Pck1 (phosphoenolpyruvate carboxykinase 1, cyto-
solic) as well as reduced expressions of enzymes involved in amino
acid degradation in the liver of sucrose fed mice were anticipated
(Fig. 4D). In the liver PGC1a is induced in response to elevated
levels of cAMP and plays a central role in the control of hepatic
gluconeogenesis [30–32]. In keeping with the increased expres-
sions of Ppargc1a and Pck1 in liver from mice fed fish oil in
combination with protein compared to sucrose, we anticipated
that gluconeogenesis was induced in the fed state in the protein fed
mice. To measure gluconeogenesis in vivo mice fed fish oil in
combination with either protein or sucrose were intraperitoneally
injected with pyruvate both after overnight fasting and in the fed
Figure 2. A high fat diet impairs glucose tolerance independent of macronutrient composition and obesity. A: Expressions of
adipogenic and inflammatory marker genes (Pparg (peroxisome proliferator activated receptor c), Adipoq (adiponectin), Serpine1 (Plasminogen
activator inhibitor-1), Ccl2 (chemokine (C-C motif) ligand 2), Emr1 (EGF-like module containing, mucin-like, hormone receptor-like sequence 1 or F4/
80) and Cd68 (CD68 antigen)) were measured in epididymal and inguinal white adipose tissue using RT-qPCR (n=8). B: Intraperitoneal glucose
tolerance test was performed in a separate set of mice (n=10). Fasting glucose and insulin levels were measured to calculate HOMA-IR. Data are
presented as means 6 SEM. Different small letters denote significant differences between the groups, in 2A within the same tissue (P,0.05).
doi:10.1371/journal.pone.0021647.g002
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In the fasted state, mice fed sucrose or protein exhibited similar
excursions, indicating similar rates of gluconeogenesis (Fig. 6A). In
fed mice, however, the rise of blood glucose following the injection
of pyruvate was dramatically faster and reached much higher levels
after 15 and 30 min in the protein fed mice than in chow fed mice
(Fig. 6A). Compared with chow fed mice the rise in blood glucose
was also increased in mice fed fish oil in combination with sucrose,
but this was not statistically significant (Fig. 6A). The decline in
blood glucose in chow fed mice remains to be explained, but this
was observed consistently. Taken together these results strongly
support the assumption that gluconeogenesis is markedly induced in
mice fed the protein-based diet.
Discussion
It is well documented that inclusion of n-3 PUFAs in high fat
diets leads to reduced development of diet-induced obesity in
rodents [7–9,11–13,33]. Unfortunately, not all studies where the
anti-obesogenic effects of fish oils are studied provide a detailed
description of the macronutrient composition. However, in
standard commercial available high fat- and very high fat diets,
starch is the most abounded carbohydrate source and the amount
of sucrose is low or absent. Here we show that a high amount of
sucrose in the diet counteracts the obesity-reducing effect of fish oil
as well as the well described anti-inflammatory effect in adipose
tissue [19,23,34,35]. Irrespective of the fatty acid source, mice fed
high protein diets remained lean whereas mice fed diets enriched
in sucrose became obese and had higher expressions of inflam-
matory markers in adipose tissue. Collectively, our results demon-
strate that a high intake of sucrose abrogates the protective effects
of fish oil in development of obesity.
As dietary sucrose, but not protein or fat, stimulates secretion of
insulin from pancreatic b-cells, an increased dietary sucrose:pro-
tein ratio will translate into an increased insulin:glucagon ratio in
the fed state. In this respect the observed higher insulin:glucagon
ratio in mice fed the sucrose-based diets than in mice fed the
protein-based diets was expected. Increased levels of insulin in fed
mice were observed irrespectively of the type of fat in the diet.
Insulin is a powerful anabolic hormone that stimulates adipocyte
differentiation and adipose tissue expansion [36]. Activation of
insulin signaling is crucial for the development of obesity [37] and
insulin receptor substrate-1 (IRS-1) transgenic mice are obese [38].
Increased insulin signaling and glucose uptake in adipose tissue
in the fed state in sucrose fed mice may thus override the
protective effect of fish oil when it comes to protection against
Table 3. Fatty acid composition in red blood cells.
High fish oil High corn oil
Low energy Sucrose Protein Sucrose Protein
Sum total (mg/g) 3.41±0.04 3.04±0.07 2.87±0.05 3.52±0.11 3.34±0.10
SFA (mg/g) 1.28±0.02 1.24±0.03 1.17±0.02 1.31±0.05 1.21±0.04
MUFA (mg/g) 0.49±0.01 0.34±0.01 0.35±0.01 0.41±0.01 0.40±0.01
PUFA (mg/g) 1.39±0.02 1.28±0.03 1.19±0.02 1.53±0.05 1.44±0.04
n-3 (mg/g) 0.2560.00 0.7960.02 0.7360.01 0.2160.01 0.1160.00
n-6 (mg/g) 1.1460.02 0.4960.01 0.4760.01 1.3260.05 1.3460.04
n-3/n-6 0.2260.00 1.6260.01 1.5560.28 0.1660.00 0.0860.00
Data are presented as mean 6 SEM (n=8).
doi:10.1371/journal.pone.0021647.t003
Table 4. Fatty acid composition in organs.
High fish oil High corn oil
Low energy Sucrose Protein Sucrose Protein
Liver
Sum total
(mg/g)
45±44 1 ±13 5 ±27 1 ±10 42±3
% 100 100 100 100 100
SFA (mg/g) 15±11 5 ±01 2 ±12 1 ±31 3 ±1
% 32.560.9 36.560.4 35.260.3 29.660.3 31.360.8
MUFA (mg/g) 13±26 ±14 ±01 9 ±47 ±1
% 29.161.6 14.962.3 11.960.7 25.661.9 17.261.3
PUFA (mg/g) 16±11 9 ±11 8 ±12 9 ±32 0 ±1
% 36.761.6 47.262.0 51.260.4 42.761.9 47.860.9
n-3 (mg/g) 3.2460.27 12.9460.51 10.8360.72 3.2860.15 1.7260.11
% 7.2560.45 31.4161.25 31.3460.35 4.9760.53 4.1060.28
n-6 (mg/g) 13616 607 602 6 631 8 61
% 29.461.2 15.860.8 19.960.5 37.761.4 43.760.7
n-3/n-6 0.2560.01 2.0060.03 1.5860.05 0.1360.01 0.0960.01
eWAT
Sum total
(mg/g)
871±14 841±17 761±78 840±27 747±43
% 100 100 100 100 100
SFA (mg/g) 198±6 250±8 208±23 155±8 120±7
% 22.760.3 29.760.5 27.360.6 18.460.6 16.160.2
MUFA (mg/g) 372±9 269±6 268±26 305±7 279±12
% 42.760.4 32.160.7 35.461.1 36.460.6 37.560.8
PUFA (mg/g) 295±2 308±8 271±29 375±14 341±24
% 33.960.6 36.660.5 35.560.7 44.560.4 45.460.7
n-3 (mg/g) 18.1660.47 114.8966.64 87.07613.22 8.6860.32 6.2560.54
% 2.0860.04 13.6360.59 11.2060.89 1.0360.02 0.8360.04
n-6 (mg/g) 277621 9 0 63 181618 366614 322622
% 31.860.6 22.660.5 23.960.6 43.560.4 44.660.7
n-3/n-6 0.0760.00 0.6060.03 0.4760.05 0.0260.00 0.0260.00
Data are presented as mean 6 SEM (n=8).
doi:10.1371/journal.pone.0021647.t004
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several studies have demonstrated a protective effect of fish oil in
obesity-development, it has been reported that inclusion of fish oil
increased the amount of adipose tissue mass in hyperinsulinemic
ob/ob mice [19].
Differences in the insulin:glucagon ratio and hence differences
in cAMP-dependent signaling may at least in part orchestrate the
observed differences in energy homeostasis between the sucrose-
and protein-based diets regardless of whether these diet are
supplemented with corn oil or fish oil. In the liver, Ppargc1a is
induced in response to elevated levels of cAMP and plays a central
role in the control of hepatic gluconeogenesis [30–32]. High
circulating levels of insulin combined with a low level of glucagon
translate into reduced cAMP signalling in the liver. Thus, the
observed increased gluconeogenesis in the fed state in protein fed
mice may result from cAMP-mediated stimulation of Ppargc1a and
Pck-1 expression. Increased gluconeogenesis in the fed state may
contribute to the observed lower energy efficiency in protein fed
Figure 3. Fish oil prevents diet-induced accumulation of fat in the liver. A: Total lipids were extracted from liver and separated using HPTLC.
B: Expressions of lipogenic genes (Srebf1 (sterol regulatory element binding transcription factor 1) and Acaca (acetyl-Coenzyme A carboxylase alpha)
were measured by RT-qPCR. C: Plasma triacylglycerol and b-hydroxybutyrate were measured in the fed state. D: Energy efficiency was calculated
based on energy intake and body weight gain. E: Expression levels of brown adipose tissue marker genes (Ucp1 (Uncoupling protein-1), Ppargc1a
(peroxisome proliferator-activated receptor gamma, coactivator 1 alpha), Cpt1b (carnitine palmitoyltransferase-1b) and Dio2 (deiodinase,
iodothyronine, type II) were measured in white adipose tissues using RT-qPCR. Data are presented as means 6 SEM (n=8). Different small letters
denote significant differences between the groups, in 3E within the same tissue (P,0.05).
doi:10.1371/journal.pone.0021647.g003
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synthesized from pyruvate, rendering gluconeogenesis an energy-
consuming process. Moreover, concomitant increased expressions
of Gpt, Got1, Agxt and Cps1 suggest that energy consuming
processes such as amino acid degradation and ureagenesis are
higher in protein than sucrose fed mice. As mammals have no
direct storage capacity for protein it needs to be metabolically
processed immediately. The high cost of urea production and
gluconeogenesis is actually often cited reasons for the higher
thermic effect of protein than other macronutrients [39,40] and
this may partly explain why diets higher in protein exert a larger
effect on energy expenditure than diets lower in protein [24].
A second mechanism by which a low sucrose:protein ratio in the
diet leads to reduced energy efficiency may be related to the observed
expression of Ucp1 in iWAT. Increased cAMP-signaling is known to
induce adaptive thermogenesis by induction of Ppargc1a and Ucp1
expression and it is well known that the UCP1 protein allows
dissipation of energy in the form of heat [41]. Of note, acute or
chronic upregulation of fatty acid oxidation alone, that is increased
fatty acid oxidation without a concomitant uncoupling of mitochon-
dria, has no net effect on whole-body energy expenditure or adiposity
[42]. Although Ucp1 expression was unchanged in iBAT, whole body
energy homeostasis may be influenced by increased expression in
iWAT. In fact, increased occurrence of brown-like adipocytes within
WAT depots is a feature of mouse strains resistant to dietary obesity,
suchastheA/Jstrain[43]andreducedadiposityassociatedwithaP2-
transgenic expression of Ucp1 is linked to increased energy dissipation
in white, but not interscapular brown, adipose tissue [29].
Conversely, inhibition of diet-induced expression of Ucp1 in iWAT
in Sv129 mice by administration of a general cyclooxygenase
inhibitor accentuates obesity-development [44].
Our finding that inclusion of sucrose abolishes the anti-obesity
effect of fish oil seems to contradict a recent study from Sato et al.
[45], as these authors demonstrated that inclusion of 5% the n-3
PUFA EPA (eicosapentaenoic acid) into a high fat-high sucrose
diet reduced body weight gain in mice. The reason for this
discrepancy is not clear, but different dietary compositions as well
as doses and type of n-3 PUFAs may account for the different
Figure 4. Sucrose counteracts the obesity-reducing effect of fish oil in pair-fed mice. Male C57BL/6 mice (n=8) were pair-fed isocaloric high
fish oil diets with different carbohydrate and protein contents for 8 weeks. A: Body weight development was followed throughout the feeding
regime. B: Energy efficiency was calculated based on energy intake, weight gain and apparent digestibility. C: The weights of different adipose tissue
depots were recorded. D: Insulin and glucagon levels were measured in plasma in the fed state. E: Inflammation and adipocyte marker genes (Pparg
(peroxisome proliferator-activated receptor c), Adipoq (adiponectin), Serpine1 (Plasminogen activator inhibitor-1), Ccl2 (chemokine (C-C motif) ligand
2), Emr1 (EGF-like module containing, mucin-like, hormone receptor-like sequence 1 or F4/80) and Cd68 (CD68 antigen) and F: thermogenesis-related
genes (Ucp1 (Uncoupling protein-1) and cyt COXII, (cytochrome c oxidase, subunit II) were measured by RT-qPCR in adipose tissues. Data are
presented as means 6 SEM. Different small letters denote significant differences between the groups, in 4E within the same tissue (P,0.05).
doi:10.1371/journal.pone.0021647.g004
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slightly higher (6% n-3 fatty acids) than the 5% EPA used by Sato
et al.. However, whereas Sato et al. used EPA, the n-3 PUFAs used
in our study comprise a mixture (thereof 3263 g/kg and 1863g /
kg EPA and DHA (docosahexaenoic acid), respectively). More-
over, in fish oil as used in our study, the n-3 PUFAs are present in
the form of triacylglycerols, whereas Sato et al. used purified EPA
ethyl ester. It should also be mentioned that the main fat source in
the diets used in our study is corn-oil rich in n-6 fatty acids,
whereas Sato et al. used anhydrate milk fat containing more than
60% saturated fat. Last, the amount of sucrose used in our study is
higher than the dose used by Sato et al. It is worth noting, how-
ever, that both the study by Sato et al. and our study demonstrated
that sucrose did not reduce the ability of fish oil and/or EPA to
prevent diet induced accumulation of fat in the liver.
A strong association between obesity and adipose tissue inflam-
mation exists and obesity is characterized by chronic low-grade
inflammation in adipose tissues [14,15]. In light of this it may not
be surprising that expression of macrophage and inflammatory
marker genes was elevated in obese mice compared to lean mice.
Still, as the anti-inflammatory effect of fish oil in adipose tissue is
well described [19,23,34,35], it was unexpected that the expression
of inflammatory markers was similar in adipose tissue from obese
corn oil and the fish oil fed groups. In our study the state of obesity
rather than the n-3:n-6 PUFA ratio in both feed and adipose
tissues appeared to determine the expression levels of inflamma-
tory markers in adipose tissue.
Chronic low grade inflammation plays an important role in
development of insulin resistance [46,47]. Pioneering work by
Storlien et al. [48], later confirmed by several others [13,23,35,
Figure 5. Metabolic parameters in mice fed fish oil in combination with sucrose or protein. A. Intraperitoneal glucose tolerance test was
performed in mice pair fed fish oil enriched diets (n=10). B. b-hydroxybutyrate, triacylglycerol, glycerol and free fatty acids were measured in pair-fed
mice in both fasted and fed state (n=10). C. Oxygen consumption, carbon dioxide and respiratory exchange ratio were measured during a 24-h
period with indirect calorimetry (n=8). Data are presented as means 6 SEM. Different small letters denote significant differences between the
groups, in 5B between fasted or fed state (P,0.05).
doi:10.1371/journal.pone.0021647.g005
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ment of diet-induced insulin resistance in rodents. The insulin
sensitizing effect of n-3 PUFAs is generally accepted to be related
to the anti-inflammatory effect, recently demonstrated to be me-
diated by the GPR120 receptor [23]. Calculation of HOMA-IR
indicated that mice fed high levels of proteins were more
insulin sensitive than mice fed sucrose, but no significant dif-
ferences was observed in an ITT. Similar to expression levels of
inflammatory markers in adipose tissue, this was irrespective of
whether the diets were supplemented with corn oil or fish oil. It
was therefore unexpected that the GTT demonstrated that mice
fed corn oil or fish oil in combination with sucrose or protein
exhibited impaired glucose tolerance irrespective of whether or not
the mice remained lean. It is possible that different mechanisms
underlay the impaired glucose tolerance observed in the sucrose
and the protein fed mice. It is likely that impaired glucose
tolerance in sucrose fed mice is related to the obese state. Of note,
in fish oil and protein fed mice, glucose tolerance was impaired
even if weight gain and inflammation were maintained at low
levels. Further studies are required to elucidate the mechanisms
underlying the impaired glucose tolerance in these mice, but the
possibility that adaption to a low carbohydrate intake with con-
comitant high hepatic gluconeogenesis and glucose output should
be considered.
Seen as a whole, our study indicate that the sucrose:protein
ratio, rather than the n-6:n-3 PUFA ratio in the diet determines
development of obesity, adipose tissue inflammation and glucose
intolerance. Activation of the NF-kB system appears to represent a
link between obesity, inflammation of adipose tissue and insulin
resistance [51–53]. Insulin is able to activate NF-kB by phos-
porylation of IkBa in different cell systems [54], thus, high levels of
circulating insulin may activate the NF-kB system also in adipose
tissue. Whether increased insulin levels in sucrose fed mice
translated into activation of the NF-kB system in adipose tissue in
these mice will require further investigation.
Together our results demonstrate that the background diet
exerts a crucial influence on the ability of n-3 PUFAs to protect
against development of obesity, glucose intolerance and adipose
tissue inflammation. High levels of dietary sucrose counteract the
anti-inflammatory effect of fish oil in adipose tissue and promote
Figure 6. Gluconeogenesis is increased in fed state when animals are fed fish oil supplemented with protein. A. Pyruvate tolerance
tests were performed on mice in 16 h fasted (n=7) and fed states (n=10). B. Hepatic gene expression (Crem (cAMP responsive element modulator),
Pde4c (phosphodiesterase 4C, cAMP specific), Ppargc1a (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha), Pck1
(phosphoenolpyruvate carboxykinase 1, cytosolic), Gpt (glutamic pyruvic transaminase), Got1 (glutamate oxaloacetate transaminase 1), Agxt
(alanine-glyoxylate aminotransferase), Cps1 (carbamoyl-phosphate synthetase 1), Acox1 (acyl-CoA oxidase 1), Cpt1a (carnitine palmitoyltransferase
1a), Cpt2 (carnitine palmitoyltransferase 2), Hmgcs2 (3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2), Srebf1 (sterol regulatory element binding
transcription factor 1), scd1 (stearoyl-Coenzyme A desaturase 1), Acaca (acetyl-Coenzyme A carboxylase alpha), Fasn (fatty acid synthase), was
measured using RT-qPCR (n=8). Data are presented as means 6 SEM. Different small letters denote significant differences between the different
groups (P,0.05).
doi:10.1371/journal.pone.0021647.g006
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societies is high and increasing dietary intake of n-3 PUFAs is
recommended by several health authorities it would be of impor-
tance to investigate whether the background diet influences the
effect of fish oil also in humans.
Materials and Methods
Ethics Statement
All animal experiments were approved by National Animal
Health Authorities (Norwegain approval identification: 1840 and
1841). Care and handling were in accordance with local insti-
tutional recommendations and rules. Adverse events were not
observed.
Animals and diets
Male C57BL/6JBomTac mice approximately 8 weeks of age
were obtained from Taconic Europe (Ejby, Denmark) and were
divided into groups (n=6–10). The mice were kept at a 12 h light/
dark cycle at 28uC. After acclimatization the animals were fed ad
libitum or pair-fed experimental diets obtained from Ssniff
Spezialdia ¨ten GmbH (Soest, Germany) described in Table 1 and
2 for 8–10 weeks. All diets were supplemented with 3 g/kg L-
cysteine, 10 g/kg choline bitartrate, 10 g/kg Vitamin mix AIN 76
A, 45 g/kg Mineral mix AIN 93 and 0.014 g/kg t-butylhydro-
quinone. Mice were euthanized by cardiac puncture under
anesthesia with Isoflurane (Isoba-vet, Schering-Plough, Denmark)
using the Univentor 400 Anaesthesia Unit (Univentor Limited,
Sweeden) in the fed state and plasma prepared from blood. Tissues
were dissected out, freeze-clamped and frozen at 280uC.
Indirect calorimetry
The metabolic rate of mice was measured by indirect calori-
metry in open circuit chambers of Labmaster system (TSE Systems
GmbH, Germany). The animals were acclimated in the chambers
for 24 hours and measured continuously for another 24 hours.
Glucose, insulin and pyruvate tolerance testing (GTT, ITT
and PTT)
GTT: mice were fasted 6 hours before intraperitoneal injection
of 2 g/kg glucose in saline. ITT: mice were fasted 4 hours before
i.p. injection of 0.5 Unit/kg human recombinant insulin in saline.
PTT: mice in the fed state or mice that were fasted overnight were
injected i.p. with of 2 g/kg pyruvate in saline. Blood was collected
from the lateral tail vein at indicated time points and measured
with Bayer Contour glucometer (Bayer A/S, Denmark).
Plasma analyses
Insulin, glucagon and glucose [25] and lipid metabolites [55]
were measured in plasma as earlier described.
Lipid analyses
Total lipids were extracted from diets, red blood cells, liver and
adipose tissue samples with chloroform: methanol, 2:1 (v/v). Lipid
classes were analyzed using an automated High-Performance Thin
Layer Chromatography (HPTLC) system (Camaq, Switzerland)
and separated on HPTLC plates coated with silica gel 60 F [55]
whereas fatty acid composition of total lipids was analyzed on a
capillary gas chromatograph with flame ionization detector (Perkin
Elmer, USA) [56].
Histology
Sections of adipose tissue were fixed, dehydrated, embedded in
paraffin blocks, cut into 3 mm thick section and stained with eosin
andhematoxylinaspreviouslydescribed [57].Sectionswerevisually
examined using an Olympus BX 51 binocular microscope (System
microscope, Japan), fitted with an Olympus DP50 3.0 camera.
RT-qPCR
Total RNA was purified from mouse tissue using Trizol
(Invitrogen). Reverse transcription (RT) was performed and cDNA
was analyzed in duplicates by qPCR using the ABI PRISM 7700
Sequence Detection System (Applied Biosystems) as earlier
described [58]. Primers for RT-qPCR were designed using Primer
Express 2.0 (Applied Biosystems) and are available on request.
Energy in faeces and diets
Energy content was determined in a bomb calorimeter fol-
lowing the manufacturer’s instruction (Parr Instruments, Moline,
IL, USA).
Statistics
Data represent mean 6 SEM. ANOVA, post hoc pairwise
comparison: Student t-test (RT-qPCR analysis) or Tukey HSD test
(GTT, ITT and organ weights). Newman-Keuls test (nonpara-
metric due to non-homogenous variances) rest of data. Data were
considered statistical significant when P,0.05).
Supporting Information
Figure S1 A high fish oil diet does not impair insulin tolerance.
Male C57BL/6 mice (n=7) were fed a low fat or isocaloric high
fish oil diets with different carbohydrate and protein contents ad
libitum for 7 weeks. A: Insulin levels were measured in the fasted
state. B: Intraperitoneal insulin tolerance test was performed. Data
are presented as means 6 SEM. Different small letters denote
significant differences between the groups.
(TIF)
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